


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+132.44%
-1.04%
+1.81%
-2.69%
-7.93%
MRNA
Moderna
$29.49
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
MRNA Price Performance
$25.49 (+15.69%)
$27.32 (+7.94%)
$25.47 (+15.78%)
$34.06 (-13.42%)
MRNA has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

MRNA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
MRNA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MRNA Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
What is MRNA current stock price?
What are MRNA stock strengths?
What is MRNA Risk Level?
What is MRNA market cap and volume?
What is MRNA current Stock IQ?
Should I buy MRNA stock right now?
Is MRNA a Strong Buy right now?
What does a 'Strong Buy' rating mean for MRNA?
What does a 'Strong Sell' rating mean for MRNA?
What factors influence MRNA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+132.44%
-1.04%
+1.81%
-2.69%
-7.93%
MRNA
Moderna
Current Price
$29.49
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

MRNA Price Performance
$25.49 (+15.69%)
$27.32 (+7.94%)
$25.47 (+15.78%)
$34.06 (-13.42%)
MRNA Analysts Opinion
MRNA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
MRNA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MRNA Street Sentiment is extremely bullish and have positive views on the near-term outlook
MRNA has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels
MRNA Stock IQ
MRNA Latest Analysis
MRNA to Get CEPI Funding for Phase III Study on Pandemic Influenza Jab. Moderna secures up to $54.3 million from CEPI to fund a pivotal phase III study of its mRNA-based H5 pandemic flu vaccine candidate mRNA-1018.
Fri Dec 19, 2025
Down 80% Should You Buy the Dip on Moderna?. Key PointsModerna&rsquo.s earnings and stock price climbed during early pandemic days -- that&rsquo.s as demand for the company&rsquo.s coronavirus vaccine soared.
Fri Dec 19, 2025
CHMP Backs EU Approval of MRNAs New COVID-19 Vaccine mNexspike. CHMP backs EU approval of Modernas next-generation mNexspike COVID-19 vaccine with a final European Commission decision expected shortly.
Tue Dec 16, 2025
Moderna Options Trading: A Deep Dive into Market Sentiment. Deep-pocketed investors have adopted a ish approach towards Moderna (NASDAQ:MRNA) and it'.s something market players shouldn'.t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown but such a substantial move in MRNA usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga
Mon Dec 15, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MRNA Stock trends
MRNA Stock performance
MRNA Stock analysis
MRNA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.